Woźniak, M.; Pastuch-Gawołek, G.; Makuch, S.; Wiśniewski, J.; Ziółkowski, P.; Szeja, W.; Krawczyk, M.; Agrawal, S.
Overcoming Hypoxia-Induced Chemoresistance in Cancer Using a Novel Glycoconjugate of Methotrexate. Pharmaceuticals 2021, 14, 13.
https://doi.org/10.3390/ph14010013
AMA Style
Woźniak M, Pastuch-Gawołek G, Makuch S, Wiśniewski J, Ziółkowski P, Szeja W, Krawczyk M, Agrawal S.
Overcoming Hypoxia-Induced Chemoresistance in Cancer Using a Novel Glycoconjugate of Methotrexate. Pharmaceuticals. 2021; 14(1):13.
https://doi.org/10.3390/ph14010013
Chicago/Turabian Style
Woźniak, Marta, Gabriela Pastuch-Gawołek, Sebastian Makuch, Jerzy Wiśniewski, Piotr Ziółkowski, Wiesław Szeja, Monika Krawczyk, and Siddarth Agrawal.
2021. "Overcoming Hypoxia-Induced Chemoresistance in Cancer Using a Novel Glycoconjugate of Methotrexate" Pharmaceuticals 14, no. 1: 13.
https://doi.org/10.3390/ph14010013
APA Style
Woźniak, M., Pastuch-Gawołek, G., Makuch, S., Wiśniewski, J., Ziółkowski, P., Szeja, W., Krawczyk, M., & Agrawal, S.
(2021). Overcoming Hypoxia-Induced Chemoresistance in Cancer Using a Novel Glycoconjugate of Methotrexate. Pharmaceuticals, 14(1), 13.
https://doi.org/10.3390/ph14010013